The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
AER Traveler Towelette
AER Traveler · WITCH HAZEL .5 g/1 · Solution · Rectal; Topical · Birchwood Laboratories LLC
NDC 50289-4200-01 · 50 PACKET in 1 CARTON / 1 APPLICATOR in 1 PACKET / 1 SOLUTION in 1 APPLICATOR · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- M015
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of AER Traveler (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Birchwood Laboratories LLC | WITCH HAZEL .5 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Isomedix Operations Inc | WITCH HAZEL .5 g/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "AER Traveler Towelette — NDC 50289-4200-01," retrieved September 3, 2026, https://drugdashboards.com/drug/50289420001.
Free to cite with attribution — see how the data is put together.